Cardiac Rhythm Management Devices Market - By Product (Pacemakers, Defibrillators, External Defibrillator, Cardiac Resynchronization Therapy Devices), By Application, End-use & Forecast, 2023

Description

Cardiac Rhythm Management Devices Market share is predicted to grow at a CAGR of over 6.2% between 2023 and 2032, driven by the aging global. The demand for cardiac rhythm management devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), rises to address age-related cardiac issues. For instance, as per CDC, in 2021, approximately 695,000 people in the United States died from heart disease-that is 1 in every 5 deaths.

Continuous R&D efforts have led to the introduction of more sophisticated and effective devices, enhancing patient outcomes and encouraging the adoption of these devices by healthcare providers. The integration of smart technologies, remote monitoring capabilities, and miniaturization of devices will further contribute to the industry's outlook.

The overall cardiac rhythm management devices industry is divided based on product, application, end-use & region.

External defibrillator segment is poised for a notable growth during 2023 and 2032, owing to its crucial role in addressing sudden cardiac arrests. With growing awareness regarding the importance of timely intervention in life-threatening situations, external defibrillators are becoming more accessible and user-friendly. The widespread use of these devices in public facilities, coupled with initiatives promoting CPR and defibrillator training, is empowering both healthcare professionals and laypersons.

As per end-use scope, cardiac care centers segment will generate notable revenues for the market during 2023-2032, backed by comprehensive diagnostic and treatment services. The expertise and advanced medical technologies available in these centers provide effective and specialized care, encouraging the incorporation of cardiac rhythm management devices as essential elements in treatment plans. These centers often serve as hubs for medical research & innovation. Their involvement in clinical trials and the integration of cutting-edge technologies will further propel the product demand.

Asia pacific cardiac rhythm management devices market is slated to witness a significant growth rate through 2032, favored by the preference for preventive healthcare, leading to increased screenings and early detection of cardiac conditions. The region's dynamic economic development results in a rise in healthcare awareness, contributing to an increased willingness among individuals to invest in advanced cardiac care technologies. The ongoing expansion of healthcare infrastructure will continue to shape the market dynamics in the APAC region in the coming years.

Product Code: 3933

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Cardiac rhythm management devices industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Application trends
2.6 End-use

Chapter 3 Cardiac Rhythm Management Devices Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of heart failure and other cardiac disorders
  - 3.2.1.2 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
  - 3.2.1.3 Increasing public awareness
  - 3.2.1.4 Rising sedentary lifestyle
  - 3.2.1.5 Favorable reimbursement scenario
  - 3.2.1.6 Growing geriatric population base coupled with rising prevalence of obesity
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of devices
  - 3.2.2.2 Product recalls
  - 3.2.2.3 Stringent regulatory approvals
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Pricing analysis, 2022
3.10 Pipeline products
3.11 Indication landscape
3.12 Startup scenario
3.13 Number of pacemaker units, 2018 -2032
3.14 Number of Defibrillators units, 2018 -2032
3.15 Number of CRT devices units, 2018 -2032
3.16 Porter's analysis
3.17 GAP analysis
3.18 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022

Chapter 5 Cardiac Rhythm Management Devices Market Size and Forecast, By Product (USD Million)

5.1 Key technology trends
5.2 Pacemakers
- 5.2.1 Implantable pacemakers
- 5.2.2 External pacemakers
5.3 Defibrillators
- 5.3.1 Implantable cardioverter defibrillator (ICDs)
  - 5.3.1.1 Transvenous implantable cardioverter defibrillator
    - 5.3.1.1.1 Single-chamber ICDs
    - 5.3.1.1.2 Dual-chamber ICDs
- 5.3.2 External Defibrillator
  - 5.3.2.1 Manual external defibrillator
  - 5.3.2.2 Automated external defibrillator
    - 5.3.2.2.1 Semi-automated external defibrillator
    - 5.3.2.2.2 Fully automated external defibrillator
  - 5.3.2.3 Wearable cardioverter defibrillator
5.4 Cardiac Resynchronization Therapy Devices
- 5.4.1 Cardiac resynchronization therapy devices- D
- 5.4.2 Cardiac resynchronization therapy devices- P

Chapter 6 Cardiac Rhythm Management Devices Market Size and Forecast, By Application (USD Million)

6.1 Key application trends
6.2 Congestive heart failure
6.3 Arrhythmias
6.4 Bradycardia
6.5 Tachycardia
6.6 Others

Chapter 7 Cardiac Rhythm Management Devices Market Size and Forecast, By End-use (USD Million)

7.1 Key end-use trends
7.2 Hospitals
7.3 Cardiac care centers
7.4 Ambulatory surgical centers
7.5 Others

Chapter 8 Cardiac Rhythm Management Devices Market Size and Forecast, By Region (USD Million)

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 South Korea
- 8.4.5 Australia
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of MEA

Chapter 9 Company Profiles

9.1 BIOTRONIK
9.2 ZOLL Medical Corporation (Asahi Kasei Group)
9.3 Boston Scientific Corporation
9.4 Abbott
9.5 Medtronic
9.6 Liva Nova
9.7 Schiller AG
9.8 Koninklijke Philips N.V.,
9.9 ABIOMED
9.10 Defibtech, LLC
9.11 Shree Pacetronix Ltd.
9.12 Osypka Medical
9.13 MicroPort Scientific Corporation
9.14 Medico S.R.L.
9.15 Vitatron
9.16 Stryker Corporation
9.17 CU Medical Systems Co. Ltd
9.18 Nihon Kohden Corporation
9.19 BPL Medical Technologies Pvt Ltd
9.20 AMI Italia

Cardiac Rhythm Management Devices Market - By Product (Pacemakers, Defibrillators, External Defibrillator, Cardiac Resynchronization Therapy Devices), By Application, End-use & Forecast, 2023 - 2032